TY - JOUR
T1 - Care Levels for Fetal Therapy Centers
AU - Baschat, Ahmet A.
AU - Blackwell, Sean B.
AU - Chatterjee, Debnath
AU - Cummings, James J.
AU - Emery, Stephen P.
AU - Hirose, Shinjiro
AU - Hollier, Lisa M.
AU - Johnson, Anthony
AU - Kilpatrick, Sarah J.
AU - Luks, Francois I.
AU - Menard, M. Kathryn
AU - McCullough, Lawrence B.
AU - Moldenhauer, Julie S.
AU - Moon-Grady, Anita J.
AU - Mychaliska, George B.
AU - Narvey, Michael
AU - Norton, Mary E.
AU - Rollins, Mark D.
AU - Skarsgard, Eric D.
AU - Tsao, Kuo Jen
AU - Warner, Barbara B.
AU - Wilpers, Abigail
AU - Ryan, Greg
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Fetal therapies undertaken to improve fetal outcome or to optimize transition to neonate life often entail some level of maternal, fetal, or neonatal risk. A fetal therapy center needs access to resources to carry out such therapies and to manage maternal, fetal, and neonatal complications that might arise, either related to the therapy per se or as part of the underlying fetal or maternal condition. Accordingly, a fetal therapy center requires a dedicated operational infrastructure and necessary resources to allow for appropriate oversight and monitoring of clinical performance and to facilitate multidisciplinary collaboration between the relevant specialties. Three care levels for fetal therapy centers are proposed to match the anticipated care complexity, with appropriate resources to achieve an optimal outcome at an institutional and regional level. A level I fetal therapy center should be capable of offering fetal interventions that may be associated with obstetric risks of preterm birth or membrane rupture but that would be very unlikely to require maternal medical subspecialty or intensive care, with neonatal risks not exceeding those of moderate prematurity. A level II center should have the incremental capacity to provide maternal intensive care and to manage extreme neonatal prematurity. A level III therapy center should offer the full range of fetal interventions (including open fetal surgery) and be able manage any of the associated maternal complications and comorbidities, as well as have access to neonatal and pediatric surgical intervention including indicated surgery for neonates with congenital anomalies.
AB - Fetal therapies undertaken to improve fetal outcome or to optimize transition to neonate life often entail some level of maternal, fetal, or neonatal risk. A fetal therapy center needs access to resources to carry out such therapies and to manage maternal, fetal, and neonatal complications that might arise, either related to the therapy per se or as part of the underlying fetal or maternal condition. Accordingly, a fetal therapy center requires a dedicated operational infrastructure and necessary resources to allow for appropriate oversight and monitoring of clinical performance and to facilitate multidisciplinary collaboration between the relevant specialties. Three care levels for fetal therapy centers are proposed to match the anticipated care complexity, with appropriate resources to achieve an optimal outcome at an institutional and regional level. A level I fetal therapy center should be capable of offering fetal interventions that may be associated with obstetric risks of preterm birth or membrane rupture but that would be very unlikely to require maternal medical subspecialty or intensive care, with neonatal risks not exceeding those of moderate prematurity. A level II center should have the incremental capacity to provide maternal intensive care and to manage extreme neonatal prematurity. A level III therapy center should offer the full range of fetal interventions (including open fetal surgery) and be able manage any of the associated maternal complications and comorbidities, as well as have access to neonatal and pediatric surgical intervention including indicated surgery for neonates with congenital anomalies.
UR - http://www.scopus.com/inward/record.url?scp=85132229793&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000004793
DO - 10.1097/AOG.0000000000004793
M3 - Article
C2 - 35675600
AN - SCOPUS:85132229793
SN - 0029-7844
VL - 139
SP - 1027
EP - 1042
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 6
ER -